Devil's Claw
Devil's claw shows a real but small and low-confidence signal for short-term low back pain at 50-100 mg harpagoside per day. Osteoarthritis evidence comes mainly from active-comparator trials without placebo arms, so it remains unproven.
What the science says
- Short-term low back pain Limited evidence
The 2014 Cochrane review of herbal medicine for low back pain concluded that daily doses standardised to 50 or 100 mg harpagoside may beat placebo for short-term pain and may reduce rescue analgesic use — but this came from just two trials totalling 315 participants, rated low-quality evidence.
- Hip and knee osteoarthritis Limited evidence
A 4-month multicentre trial in 122 patients found powdered Harpagophytum (2610 mg/day) comparable to diacerein 100 mg/day for pain and function, with fewer adverse events. There was no placebo arm, and diacerein itself has weak efficacy, so this shows non-inferiority to a modest comparator rather than proven benefit.
- NSAID sparing Limited evidence
One low-quality trial (n = 88) reported rough equivalence to rofecoxib 12.5 mg/day for back pain. That drug has since been withdrawn from the market, and no well-powered trial has tested devil's claw against a current NSAID.
Dosage & safety
Scientific references
Where to buy
Nature's Answer, Devil's Claw Extract, Alcohol-Free, 1,000 mg, 1 fl oz (30 ml)
View on iHerbReferral link — this site may earn a commission on purchases.
Related in Joints & skin
- Curcumin (Turmeric extract) Moderate evidence
- Collagen Peptides Moderate evidence
- Glucosamine Limited evidence
- Biotin (Vitamin B7) Limited evidence
- MSM (Methylsulfonylmethane) Limited evidence
- Chondroitin Sulfate Moderate evidence